← FDA Drug Approvals (Drugs@FDA)

RELISTOR

NDA · New Drug Application · Sponsor: SALIX PHARMS · Approved 2008-04-24

Drug application

FDA Application #

NDA021964

Application type

New Drug Application

Brand name

RELISTOR

Generic name

METHYLNALTREXONE BROMIDE

Active ingredients

METHYLNALTREXONE BROMIDE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

SALIX PHARMS

Manufacturer

Salix Pharmaceuticals, Inc.

First approval

2008-04-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown